Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	18,685	31,846	43,545	84,490	37,696	438	Upgrade
Market Cap Growth	-71.21%	-26.87%	-48.46%	124.14%	8507.53%	-13.41%	Upgrade
Enterprise Value	16,646	29,610	41,909	83,203	37,702	416	Upgrade
Last Close Price	1.15	1.96	2.68	5.20	2.32	0.16	Upgrade
PE Ratio	24.72	22.14	33.08	156.33	-	-	Upgrade
PS Ratio	6.62	8.96	15.83	80.44	845.53	7.20	Upgrade
PB Ratio	4.07	7.09	14.24	48.61	31.40	2.69	Upgrade
P/TBV Ratio	4.07	7.09	14.24	48.63	31.44	2.73	Upgrade
P/FCF Ratio	-	62.27	56.88	-	-	-	Upgrade
P/OCF Ratio	-	60.84	56.66	-	-	-	Upgrade
EV/Sales Ratio	5.90	8.33	15.24	79.22	845.67	6.84	Upgrade
EV/EBITDA Ratio	14.93	16.11	25.01	139.68	-	-	Upgrade
EV/EBIT Ratio	15.22	16.17	25.09	140.86	-	-	Upgrade
EV/FCF Ratio	-96.25	57.90	54.75	-	-	-	Upgrade
Debt / Equity Ratio	0.01	0.01	0.01	0.03	0.01	0.08	Upgrade
Debt / EBITDA Ratio	0.03	0.01	0.02	0.09	-	-	Upgrade
Debt / FCF Ratio	-	0.05	0.05	-	-	-	Upgrade
Asset Turnover	0.58	0.81	0.94	0.65	0.06	0.13	Upgrade
Quick Ratio	9.69	12.19	4.26	10.13	15.07	0.44	Upgrade
Current Ratio	9.71	12.21	4.26	10.16	15.14	0.77	Upgrade
Return on Equity (ROE)	17.92%	38.13%	54.91%	36.78%	-9.26%	-13.74%	Upgrade
Return on Assets (ROA)	13.95%	25.95%	35.50%	22.79%	-4.75%	-8.38%	Upgrade
Return on Capital (ROIC)	16.08%	30.08%	42.71%	24.53%	-5.40%	-22.16%	Upgrade
Return on Capital Employed (ROCE)	23.70%	40.50%	54.00%	33.00%	-	-	Upgrade
Earnings Yield	4.05%	4.52%	3.02%	0.64%	-0.17%	-5.18%	Upgrade
FCF Yield	-0.93%	1.61%	1.76%	-0.46%	-0.13%	-12.20%	Upgrade
Buyback Yield / Dilution	-	-	-	-211.43%	-96.58%	-4.95%	Upgrade

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.